Offstream
news

The U.S. FDA grants approval for the Pfizer–BioNTech COVID-19 vaccine for people aged between 12 and 17.
2022-07-8

Queen Margrethe II tests positive for COVID-19, with mild symptoms.
2022-02-9

The Food and Drug Administration authorizes the use of the Pfizer–BioNTech COVID-19 vaccine as a booster dose for children between the ages of 12 and 15 years, becoming the world's first vaccine to be authorized as a booster shot for this age group.
2022-01-3

The Food and Drug Administration grants emergency use authorization for Merck & Co.'s antiviral COVID-19 oral pill named Molnupiravir for at-risk individuuals.
2021-12-23

The Food and Drug Administration officially authorizes the usage of a third dosage of the Pfizer–BioNTech COVID-19 vaccine as a booster shot for individuals still considered vulnerable to COVID-19. Among those eligible are health care workers and senior citizens who have been fully inoculated with the vaccine for at least six months.
2021-09-22

Moderna says that it has requested full approval for its vaccine from the U.S. Food and Drug Administration. Currently, it has only been approved for emergency use.
2021-06-1

The Swedish government announces that all travellers will be required to show a negative COVID-19 testing result within 48 hours of arrival beginning February 6 in order to prevent the spread of variants of SARS-CoV-2. Swedish citizens as well as foreign residents living in Sweden will be exempt from this rule.
2021-02-3

The Centers for Disease Control and Prevention announces that American passengers traveling from the United Kingdom will be required to test negative for COVID-19 within 72 hours due to the emergence of a new variant of SARS-CoV-2. The order is expected to take effect on December 28.
2020-12-24

Moderna announces that they will seek approval from the Food and Drug Administration and European regulators such as the European Medicines Agency for their potential vaccine after it showed a 94% effectiveness.
2020-11-30

The U.S. Food and Drug Administration grants an emergency use authorization for Regeneron Pharmaceuticals' antibody cocktail to treat COVID-19 patients. The cocktail was previously given to President Donald Trump during his hospitalization for COVID-19 last month.
2020-11-21